Search Results - Marc Ferrante
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways by Marileen M. Prins, Bram Verstockt, Bram Verstockt, Marc Ferrante, Marc Ferrante, Séverine Vermeire, Séverine Vermeire, Manon E. Wildenberg, Manon E. Wildenberg, Pim J. Koelink
Published in Frontiers in Immunology (2021-03-01)Get full text
Article -
2
-
3
Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD by Séverine Vermeire, Marc Ferrante, Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, João Sabino, Sare Verstockt
Published in BMJ Open Gastroenterology (2023-08-01)Get full text
Article -
4
Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis by Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Published in Pharmaceutics (2021-10-01)Get full text
Article -
5
Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational... by Roni Weisshof, Stephan R. Vavricka, Lieven Pouillon, Fiona Braegger, Montserrat Roset, Nawal Bent-Ennakhil, Marc Ferrante
Published in BMC Gastroenterology (2023-11-01)Get full text
Article -
6
Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression by Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Severine Vermeire
Published in iScience (2022-05-01)Get full text
Article -
7
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease by Bram Verstockt, Bram Verstockt, Clémentine Perrier, Clémentine Perrier, Gert De Hertogh, Jonathan Cremer, Jonathan Cremer, Brecht Creyns, Brecht Creyns, Gert Van Assche, Gert Van Assche, Marc Ferrante, Marc Ferrante, Jan L. Ceuppens, Séverine Vermeire, Séverine Vermeire, Christine Breynaert
Published in Frontiers in Immunology (2018-12-01)Get full text
Article -
8
Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment by Elise Schoefs, Séverine Vermeire, Séverine Vermeire, Marc Ferrante, Marc Ferrante, João Sabino, João Sabino, Bram Verstockt, Bram Verstockt, Luisa Avedano, Maria Stella De Rocchis, Magdalena Sajak-Szczerba, Roberto Saldaña, Noortje Straetemans, Noortje Straetemans, Martina Vandebroek, Rosanne Janssens, Isabelle Huys
Published in Frontiers in Medicine (2024-08-01)Get full text
Article -
9
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study by Jeroen Geldof, Jeroen Geldof, Marie Truyens, Marie Truyens, João Sabino, João Sabino, Marc Ferrante, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, Elizaveta Padalko, Elizaveta Padalko, Triana Lobaton, Triana Lobaton, Séverine Vermeire, Séverine Vermeire
Published in Frontiers in Immunology (2023-03-01)Get full text
Article -
10
-
11
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium by Brecht Creyns, Brecht Creyns, Inge Jacobs, Bram Verstockt, Bram Verstockt, Jonathan Cremer, Jonathan Cremer, Vera Ballet, Roselien Vandecasteele, Tim Vanuytsel, Tim Vanuytsel, Marc Ferrante, Marc Ferrante, Séverine Vermeire, Séverine Vermeire, Gert Van Assche, Gert Van Assche, Jan L. Ceuppens, Christine Breynaert, Christine Breynaert
Published in Frontiers in Immunology (2020-08-01)Get full text
Article -
12
Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases by Wannee Kantasiripitak, An Outtier, Sebastian G. Wicha, Alexander Kensert, Zhigang Wang, João Sabino, Séverine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen
Published in CPT: Pharmacometrics & Systems Pharmacology (2022-08-01)Get full text
Article -
13
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseResearch in context by Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Published in EBioMedicine (2019-02-01)Get full text
Article -
14
Using provocative design to foster electronic informed consent innovation by Evelien De Sutter, Stef Verreydt, Koen Yskout, David Geerts, Pascal Borry, An Outtier, Marc Ferrante, Corinne Vandermeulen, Nele Vanmechelen, Bart Van der Schueren, Isabelle Huys
Published in BMC Medical Informatics and Decision Making (2022-11-01)Get full text
Article -
15
Microbiota, not host origin drives ex vivo intestinal epithelial responses by Kaline Arnauts, Padhmanand Sudhakar, Sare Verstockt, Cynthia Lapierre, Selina Potche, Clara Caenepeel, Bram Verstockt, Jeroen Raes, Séverine Vermeire, João Sabino, Catherine Verfaillie, Marc Ferrante
Published in Gut Microbes (2022-12-01)Get full text
Article -
16
SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity by Mona Farhadipour, Kaline Arnauts, Mathias Clarysse, Theo Thijs, Kathrin Liszt, Bart Van der Schueren, Laurens J. Ceulemans, Ellen Deleus, Matthias Lannoo, Marc Ferrante, Inge Depoortere
Published in iScience (2023-12-01)Get full text
Article -
17
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELC... by Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, Triana Lobaton, Elizaveta Padalko, Séverine Vermeire
Published in Vaccines (2024-10-01)Get full text
Article -
18
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies by Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, Marc Ferrante, Satoshi Motoya, Remo Panaccione, Joana Torres, Ryan C. Ungaro, Kristina Kligys, Jasmina Kalabic, Javier Zambrano, Yafei Zhang, Geert D'Haens
Published in Gastro Hep Advances (2024-01-01)Get full text
Article -
19
Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn’s Disease by Brian G. Feagan, Remo Panaccione, Stefan Schreiber, Edward V. Loftus, Jr., Laurent Peyrin-Biroulet, Takehiro Arai, Wan-Ju Lee, Jenny Griffith, Jasmina Kalabic, Kristina Kligys, Si Xuan, Xiaomei Liao, Marc Ferrante
Published in Gastro Hep Advances (2025-01-01)Get full text
Article -
20
Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease by Brian G. Feagan, Jean-Frederic Colombel, Remo Panaccione, Stefan Schreiber, Marc Ferrante, Koji Kamikozuru, Christopher Ma, Wan-Ju Lee, Jenny Griffith, Namita Joshi, Kristina Kligys, Jasmina Kalabic, Si Xuan, Marla Dubinsky
Published in Gastro Hep Advances (2025-01-01)Get full text
Article
